Levocloperastine 20mg + Chlorpheniramine 4mg | SARITUS-CPM

Coming Soon

SARITUS-CPM Suspension combines Levocloperastine Fendizoate 35.4 mg equivalent to Levocloperastine HCl 20 mg with Chlorpheniramine Maleate 4 mg per 5 mL. It is formulated for symptomatic relief of dry cough and associated allergic symptoms under healthcare-professional guidance.

Product Specifications

Composition: Each 5 ml of Susp. contains: Levocloperastine Fendizoate 35.4 mg equivalent to Levocloperastine Hcl 20 mg +Chlorpheniramine Maleate 4 MG
Dosage Form: Suspension

Additional information

Product Name

SARITUS CPM Suspension

Generic Name

Levocloperastine Fendizoate + Chlorpheniramine Maleate

Composition

Each 5 ml of Susp. contains: Levocloperastine Fendizoate 35.4 mg equivalent to Levocloperastine Hcl 20 mg +Chlorpheniramine Maleate 4 MG

Dosage Form

Therapeutic Categories

Drug Class

Antitussive + First-Generation H1 Antihistamine

Indication

Symptomatic relief of dry, non-productive cough, particularly where an allergic component may be present.

Target Infections - Conditions

Dry cough, Non-productive cough, Irritative cough, Allergy-associated cough, Upper respiratory tract symptoms associated with cough

Strength

Per 5 mL: Levocloperastine Fendizoate 35.4 mg equivalent to Levocloperastine HCl 20 mg + Chlorpheniramine Maleate 4 mg

Pack Size

100 mL

Packaging Type

Not Available

Storage Conditions

Store in a cool and dry place below 25?C. Protect from moisture and direct sunlight.

Prescription Status

Rx (To be taken under medical supervision)